RxDoctor Payments Data

Kelechi Akuma, MD

Vascular Surgery · Bay Shore, NYNPI 1649539339

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $12,915 of the $20,085 with a category attached, or 64.3%. It is spread thinly across 28 manufacturers, the largest accounting for just 21.3%. 2025 is the largest year on record at $5,606, 2.2 times the $2,539 reported in 2019.

$20,085in general payments, 2019–2025

Across 260 payments — averaging $77.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Angiodynamics, Inc.$4K
  • W. L. Gore & Associates, Inc.$4K
  • Cook Medical LLC$3K
  • Penumbra, Inc.$2K
  • Bolton Medical Inc$1K
  • Avinger Inc.$1K
  • plus $5K from 22 others

What the payments were for

  • Travel & lodging$3,70318%
  • Food & beverage$12,91564%
  • Education$4122%
  • Other$3,05615%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$20,085 in reported general payments places this provider in the 75th percentile of 405 vascular surgery providers in New York.

See all vascular surgery providers in New York →

Medicare billing

Part B allowed, 2024
$80,789
Medicare patients
147
Services billed
351

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
XareltoRivaroxaban20$18,391
EliquisApixaban12$12,123
ClopidogrelClopidogrel Bisulfate24$212

Paid to pharmacies, not to this prescriber.

Other vascular surgery in Bay Shore

See the full list for New York →

Where these figures come from

Is this you, or does something look wrong? →